CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 26 enrolled
Drug / intervention
Procellera™ Antimicrobial Dressing +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00816101
NCT00816101Phase 2Completed
CompareCT.gov

Efficacy of the PROCELLERA™ Wound Dressing in the Healing of Wounds After a Curettage and Electrodesiccation of Skin Lesions

Vomaris Innovations·interventional·Posted Dec 31, 2008·Updated Mar 9, 2011

In Brief

A Phase 2 clinical trial evaluating Procellera™ Antimicrobial Dressing, Mepilex® Border Lite, and 1 other intervention for Acute Wounds. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The purpose of this pilot clinical study is to compare healing rates, pain levels, and incidence of wound complications including infection with the use of a moist PROCELLERA™ Antimicrobial Wound Dressing when compared to a standard dressing, Mepilex® Border Lite, following curettage and electrodesiccation of skin lesions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Wounds
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 31, 2008
Enrollment StartMar 1, 2008
Primary CompletionSep 1, 2008
Study CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 17.5 years ago

Interventions

Procellera™ Antimicrobial Dressingother

Dressing indicated for partial and full-thickness wounds.

Mepilex® Border Liteother

Self-adherent foam dressing

Adhesive Bandagedevice

Adhesive bandage